Untargeted Plasma Metabolomics and Gut Microbiome Profiling Provide Novel Insights into the Regulation of Platelet Reactivity in Healthy Individuals

Abstract

Background Considerable variation exists in platelet reactivity to stimulation among healthy individuals. Various metabolites and metabolic pathways influence platelet reactivity, but a comprehensive overview of these associations is missing. The gut microbiome has a strong influence on the plasma metabolome. Here, we investigated the association of platelet reactivity with results of untargeted plasma metabolomics and gut microbiome profiling.

Methods We used data from a cohort of 534 healthy adult Dutch volunteers (the 500 Functional Genomics study). Platelet activation and reactivity were measured by the expression of the alpha-granule protein P-selectin and the binding of fibrinogen to the activated integrin αIIbβ3, both in unstimulated blood and after ex vivo stimulation with platelet agonists. Plasma metabolome was measured using an untargeted metabolic profiling approach by quadrupole time-of-flight mass spectrometry. Gut microbiome data were measured by shotgun metagenomic sequencing from stool samples.

Results Untargeted metabolomics yielded 1,979 metabolites, of which 422 were identified to play a role in a human metabolic pathway. Overall, 92/422 (21.8%) metabolites were significantly associated with at least one readout of platelet reactivity. The majority of associations involved lipids, especially members of eicosanoids, including prostaglandins and leukotrienes. Dietary-derived polyphenols were also found to inhibit platelet reactivity. Validation of metabolic pathways with functional microbial profiles revealed two overlapping metabolic pathways (“alanine, aspartate, and glutamate metabolism” and “arginine biosynthesis”) that were associated with platelet reactivity.

Conclusion This comprehensive overview is an resource for understanding the regulation of platelet reactivity by the plasma metabolome and the possible contribution of the gut microbiota.

Keywords

metabolome - microbiome - platelet - platelet reactivity

Publication History

Received: 18 January 2021

Accepted: 28 June 2021

Accepted Manuscript online:
30 June 2021

Article published online:
13 August 2021

• References

• 1 Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood 2015; 126 (05) 582-588
• 2 Lindkvist M, Fernberg U, Ljungberg LU. et al. Individual variations in platelet reactivity towards ADP, epinephrine, collagen and nitric oxide, and the association to arterial function in young, healthy adults. Thromb Res 2019; 174: 5-12
• 3 Puurunen MK, Hwang SJ, Larson MG. et al. ADP platelet hyperreactivity predicts cardiovascular disease in the FHS (Framingham Heart Study). J Am Heart Assoc 2018; 7 (05) e008522
• 4 Jones CI, Bray S, Garner SF. et al; Bloodomics Consortium. A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood 2009; 114 (07) 1405-1416
• 5 Johnson AD, Yanek LR, Chen MH. et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010; 42 (07) 608-613
• 6 Miller CH, Rice AS, Garrett K, Stein SF. Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results. Br J Haematol 2014; 165 (06) 842-853
• 7 Yeung J, Hawley M, Holinstat M. The expansive role of oxylipins on platelet biology. J Mol Med (Berl) 2017; 95 (06) 575-588
• 8 Vallance TM, Ravishankar D, Albadawi DAI, Osborn HMI, Vaiyapuri S. Synthetic flavonoids as novel modulators of platelet function and thrombosis. Int J Mol Sci 2019; 20 (12) E3106
• 9 Roşca AE, Vlădăreanu AM, Mititelu A. et al. Effects of exogenous androgens on platelet activity and their thrombogenic potential in supraphysiological administration: a literature review. J Clin Med 2021; 10 (01) E147
• 10 Nicholson G, Rantalainen M, Maher AD. et al; The Molpage Consortium. Human metabolic profiles are stably controlled by genetic and environmental variation. Mol Syst Biol 2011; 7: 525
• 11 Sridharan GV, Choi K, Klemashevich C. et al. Prediction and quantification of bioactive microbiota metabolites in the mouse gut. Nat Commun 2014; 5: 5492
• 12 Wilmanski T, Rappaport N, Earls JC. et al. Blood metabolome predicts gut microbiome α-diversity in humans. Nat Biotechnol 2019; 37 (10) 1217-1228
• 13 Ter Horst R, Jaeger M, Smeekens SP. et al. Host and environmental factors influencing individual human cytokine responses. Cell 2016; 167 (04) 1111.e13-1124.e13
• 14 Tunjungputri RN, Li Y, de Groot PG. et al. The inter-relationship of platelets with interleukin-1β-mediated inflammation in humans. Thromb Haemost 2018; 118 (12) 2112-2125
• 15 Feist AM, Henry CS, Reed JL. et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 2007; 3: 121
• 16 Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 2017; 45 (D1): D353-D361
• 17 Schirmer M, Smeekens SP, Vlamakis H. et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 2016; 167 (04) 1125-1136
• 18 Chong J, Soufan O, Li C. et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 2018; 46 (W1): W486-W494
• 19 Stevens VL, Hoover E, Wang Y, Zanetti KA. Pre-analytical factors that affect metabolite stability in human urine, plasma, and serum: a review. Metabolites 2019; 9 (08) E156
• 20 Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79 (05) 727-747
• 21 Iyú D, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. Platelets 2010; 21 (05) 329-342
• 22 Kashiwagi H, Yuhki KI, Imamichi Y. et al. Prostaglandin F2α facilitates platelet activation by acting on prostaglandin E2 receptor subtype EP3 and thromboxane A2 receptor TP in mice. Thromb Haemost 2019; 119 (08) 1311-1320
• 23 Rybicki JP, Le Breton GC. Prostaglandin H2 directly lowers human platelet cAMP levels. Thromb Res 1983; 30 (05) 407-414
• 24 Setty BN, Werner MH, Hannun YA, Stuart MJ. 15-Hydroxyeicosatetraenoic acid-mediated potentiation of thrombin-induced platelet functions occurs via enhanced production of phosphoinositide-derived second messengers–sn-1,2-diacylglycerol and inositol-1,4,5-trisphosphate. Blood 1992; 80 (11) 2765-2773
• 25 Diehl P, Nienaber F, Zaldivia MTK. et al. Lysophosphatidylcholine is a major component of platelet microvesicles promoting platelet activation and reporting atherosclerotic plaque instability. Thromb Haemost 2019; 119 (08) 1295-1310
• 26 Haserück N, Erl W, Pandey D. et al. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 2004; 103 (07) 2585-2592
• 27 Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002; 68–69: 3-58
• 28 Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr 2003; 77 (03) 700-706
• 29 Freedman JE, Keaney Jr JF. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr 2001; 131 (02) 374S-377S
• 30 Jing L, Yanyan Z, Junfeng F. Acetic acid in aged vinegar affects molecular targets for thrombus disease management. Food Funct 2015; 6 (08) 2845-2853
• 31 Al-Shiblawi NK. Role of Kynurenine on Platelet's Function and Beyond. Dublin: Trinity College Dublin; School of Pharmacy & Pharmaceutical Sciences; 2020
• 32 Aibibula M, Naseem KM, Sturmey RG. Glucose metabolism and metabolic flexibility in blood platelets. J Thromb Haemost 2018; 16 (11) 2300-2314
• 33 Högberg C, Gidlöf O, Tan C. et al. Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3-kinase-β signaling. J Thromb Haemost 2011; 9 (02) 361-372
• 34 Bertoni A, Rastoldo A, Sarasso C. et al. Dehydroepiandrosterone-sulfate inhibits thrombin-induced platelet aggregation. Steroids 2012; 77 (03) 260-268
• 35 Banerjee D, Mazumder S, Bhattacharya S, Sinha AK. The sex specific effects of extraneous testosterone on ADP induced platelet aggregation in platelet-rich plasma from male and female subjects. Int J Lab Hematol 2014; 36 (05) e74-e77
• 36 Patneau DK, Mayer ML. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci 1990; 10 (07) 2385-2399
• 37 Green TN, Hamilton JR, Morel-Kopp MC. et al. Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis. Platelets 2017; 28 (08) 799-811
• 38 Mauri MC, Ferrara A, Boscati L. et al. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 1998; 37 (03) 124-129
• 39 Summar ML, Gainer JV, Pretorius M. et al. Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function. Hypertension 2004; 43 (02) 186-191
• 40 Liu Y, Hou Y, Wang G, Zheng X, Hao H. Gut microbial metabolites of aromatic amino acids as signals in host-microbe interplay. Trends Endocrinol Metab 2020; 31 (11) 818-834
• 41 Newsome SD, Feeser KL, Bradley CJ, Wolf C, Takacs-Vesbach C, Fogel ML. Isotopic and genetic methods reveal the role of the gut microbiome in mammalian host essential amino acid metabolism. Proc Biol Sci 2020; 287 (1922): 20192995
• 42 Woodmansey EJ, McMurdo ME, Macfarlane GT, Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 2004; 70 (10) 6113-6122
• 43 Pell VR, Spiroski A-M, Mulvey J. et al. Ischemic preconditioning protects against cardiac ischemia reperfusion injury without affecting succinate accumulation or oxidation. J Mol Cell Cardiol 2018; 123: 88-91
• 44 Strandwitz P, Kim KH, Terekhova D. et al. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol 2019; 4 (03) 396-403
• 45 Rainesalo S, Keränen T, Saransaari P, Honkaniemi J. GABA and glutamate transporters are expressed in human platelets. Brain Res Mol Brain Res 2005; 141 (02) 161-165
• 46 Lin KH, Lu WJ, Wang SH. et al. Characteristics of endogenous γ-aminobutyric acid (GABA) in human platelets: functional studies of a novel collagen glycoprotein VI inhibitor. J Mol Med (Berl) 2014; 92 (06) 603-614
• 47 Zhu W, Gregory JC, Org E. et al. Gut Microbial Metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 2016; 165 (01) 111-124
• 48 Nemet I, Saha PP, Gupta N. et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 2020; 180 (05) 862.e22-877.e22